Bio Historical Financial Ratios

BIO Stock

USD 289.45 2.43 0.83%

Bio Rad is presently reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.15 or Days Sales Outstanding of 87.35 will help investors to properly organize and evaluate Bio Rad Laboratories financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

About Bio Financial Ratios Analysis

Bio Rad LaboratoriesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bio Rad investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bio Rad history.

Bio Rad Financial Ratios Chart

Bio Rad Laboratories financial ratios usually calculated using numerical values taken directly from Bio Rad financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Bio Rad. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.

At this time, Bio Rad's Stock Based Compensation To Revenue is very stable compared to the past year. As of the 22nd of May 2024, PB Ratio is likely to grow to 2.15, while Invested Capital is likely to drop 0.13.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Bio Rad Laboratories stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bio Rad sales, a figure that is much harder to manipulate than other Bio Rad Laboratories multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Most ratios from Bio Rad's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bio Rad Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	52.9	64.43	68.45	87.35
PTB Ratio	1.65	1.3	1.08	2.15

Days Sales Outstanding Ptb Ratio

Bio Rad fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Invested Capital	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		-0.2	-0.56	0.9	0.04	-0.69	0.8	0.45	-0.2	1.0	0.83	-0.47	-0.06	0.56	0.07	-0.53	0.69	0.39	0.44	0.65	0.58	0.06	0.59	-0.4	0.36	0.4
Ptb Ratio	-0.2		0.55	-0.37	-0.7	0.6	-0.43	-0.65	1.0	-0.21	-0.3	0.41	0.28	0.09	-0.29	-0.22	-0.09	-0.6	-0.05	-0.1	-0.71	-0.41	0.13	0.11	0.24	0.0
Days Sales Outstanding	-0.56	0.55		-0.41	-0.39	0.55	-0.6	-0.37	0.55	-0.52	-0.61	0.44	0.1	-0.47	-0.2	0.35	-0.43	-0.07	-0.13	-0.5	-0.66	-0.36	-0.42	-0.09	-0.35	-0.07
Book Value Per Share	0.9	-0.37	-0.41		0.1	-0.66	0.78	0.44	-0.37	0.93	0.76	-0.44	-0.01	0.3	-0.01	-0.22	0.55	0.66	0.36	0.61	0.62	0.24	0.29	-0.52	0.05	0.34
Free Cash Flow Yield	0.04	-0.7	-0.39	0.1		-0.37	0.53	0.52	-0.7	0.03	0.42	-0.16	0.19	0.22	-0.2	0.32	-0.06	0.31	-0.39	0.04	0.77	0.31	-0.26	0.01	0.19	-0.45
Invested Capital	-0.69	0.6	0.55	-0.66	-0.37		-0.65	-0.87	0.6	-0.69	-0.55	0.84	0.34	-0.28	-0.29	0.38	-0.35	-0.57	-0.41	-0.29	-0.71	-0.05	-0.47	0.11	-0.06	-0.33
Operating Cash Flow Per Share	0.8	-0.43	-0.6	0.78	0.53	-0.65		0.47	-0.43	0.8	0.98	-0.41	0.21	0.69	-0.21	-0.13	0.41	0.39	-0.09	0.6	0.88	0.31	0.21	-0.33	0.52	-0.15
Capex To Depreciation	0.45	-0.65	-0.37	0.44	0.52	-0.87	0.47		-0.65	0.45	0.38	-0.6	-0.41	0.12	0.36	-0.18	0.41	0.56	0.36	0.04	0.65	-0.05	0.26	-0.15	-0.03	0.29
Pb Ratio	-0.2	1.0	0.55	-0.37	-0.7	0.6	-0.43	-0.65		-0.21	-0.3	0.41	0.28	0.09	-0.29	-0.22	-0.09	-0.6	-0.05	-0.1	-0.71	-0.41	0.13	0.11	0.24	0.0
Ev To Sales	1.0	-0.21	-0.52	0.93	0.03	-0.69	0.8	0.45	-0.21		0.82	-0.47	-0.07	0.51	0.07	-0.49	0.67	0.45	0.45	0.63	0.57	0.07	0.55	-0.44	0.3	0.42
Free Cash Flow Per Share	0.83	-0.3	-0.61	0.76	0.42	-0.55	0.98	0.38	-0.3	0.82		-0.31	0.25	0.76	-0.23	-0.2	0.52	0.27	-0.08	0.63	0.81	0.3	0.27	-0.37	0.62	-0.14
Roic	-0.47	0.41	0.44	-0.44	-0.16	0.84	-0.41	-0.6	0.41	-0.47	-0.31		0.39	-0.1	-0.33	0.36	-0.08	-0.45	-0.3	-0.11	-0.5	-0.11	-0.4	-0.08	0.07	-0.24
Inventory Turnover	-0.06	0.28	0.1	-0.01	0.19	0.34	0.21	-0.41	0.28	-0.07	0.25	0.39		0.3	-0.98	0.24	-0.1	-0.3	-0.57	0.43	0.08	0.26	-0.31	-0.05	0.32	-0.56
Net Income Per Share	0.56	0.09	-0.47	0.3	0.22	-0.28	0.69	0.12	0.09	0.51	0.76	-0.1	0.3		-0.24	-0.33	0.33	-0.35	-0.2	0.59	0.43	-0.06	0.39	-0.07	0.94	-0.27
Days Of Inventory On Hand	0.07	-0.29	-0.2	-0.01	-0.2	-0.29	-0.21	0.36	-0.29	0.07	-0.23	-0.33	-0.98	-0.24		-0.24	0.13	0.21	0.58	-0.34	-0.1	-0.28	0.32	0.06	-0.26	0.57
Payables Turnover	-0.53	-0.22	0.35	-0.22	0.32	0.38	-0.13	-0.18	-0.22	-0.49	-0.2	0.36	0.24	-0.33	-0.24		-0.48	0.12	-0.55	-0.29	-0.03	0.19	-0.98	-0.12	-0.27	-0.51
Capex To Revenue	0.69	-0.09	-0.43	0.55	-0.06	-0.35	0.41	0.41	-0.09	0.67	0.52	-0.08	-0.1	0.33	0.13	-0.48		0.14	0.47	0.38	0.33	0.03	0.47	-0.51	0.26	0.45
Cash Per Share	0.39	-0.6	-0.07	0.66	0.31	-0.57	0.39	0.56	-0.6	0.45	0.27	-0.45	-0.3	-0.35	0.21	0.12	0.14		0.3	-0.04	0.52	0.27	-0.07	-0.38	-0.5	0.3
Pocfratio	0.44	-0.05	-0.13	0.36	-0.39	-0.41	-0.09	0.36	-0.05	0.45	-0.08	-0.3	-0.57	-0.2	0.58	-0.55	0.47	0.3		0.14	-0.17	-0.5	0.58	-0.2	-0.33	0.99
Interest Coverage	0.65	-0.1	-0.5	0.61	0.04	-0.29	0.6	0.04	-0.1	0.63	0.63	-0.11	0.43	0.59	-0.34	-0.29	0.38	-0.04	0.14		0.33	0.07	0.35	-0.18	0.37	0.11
Capex To Operating Cash Flow	0.58	-0.71	-0.66	0.62	0.77	-0.71	0.88	0.65	-0.71	0.57	0.81	-0.5	0.08	0.43	-0.1	-0.03	0.33	0.52	-0.17	0.33		0.52	0.09	-0.2	0.29	-0.23
Pfcf Ratio	0.06	-0.41	-0.36	0.24	0.31	-0.05	0.31	-0.05	-0.41	0.07	0.3	-0.11	0.26	-0.06	-0.28	0.19	0.03	0.27	-0.5	0.07	0.52		-0.21	0.06	-0.09	-0.49
Days Payables Outstanding	0.59	0.13	-0.42	0.29	-0.26	-0.47	0.21	0.26	0.13	0.55	0.27	-0.4	-0.31	0.39	0.32	-0.98	0.47	-0.07	0.58	0.35	0.09	-0.21		0.14	0.3	0.52
Income Quality	-0.4	0.11	-0.09	-0.52	0.01	0.11	-0.33	-0.15	0.11	-0.44	-0.37	-0.08	-0.05	-0.07	0.06	-0.12	-0.51	-0.38	-0.2	-0.18	-0.2	0.06	0.14		-0.04	-0.22
Roe	0.36	0.24	-0.35	0.05	0.19	-0.06	0.52	-0.03	0.24	0.3	0.62	0.07	0.32	0.94	-0.26	-0.27	0.26	-0.5	-0.33	0.37	0.29	-0.09	0.3	-0.04		-0.39
Ev To Operating Cash Flow	0.4	0.0	-0.07	0.34	-0.45	-0.33	-0.15	0.29	0.0	0.42	-0.14	-0.24	-0.56	-0.27	0.57	-0.51	0.45	0.3	0.99	0.11	-0.23	-0.49	0.52	-0.22	-0.39

Click cells to compare fundamentals

Bio Rad Account Relationship Matchups

Bio Rad fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	4.78	6.82	7.71	4.47	3.53	3.71
Ptb Ratio	1.92	1.76	1.65	1.3	1.08	2.15
Days Sales Outstanding	62.0	60.14	52.9	64.43	68.45	87.35
Book Value Per Share	192.84	331.9	458.15	322.82	299.26	314.22
Free Cash Flow Yield	0.0325	0.0275	0.0238	0.006411	0.0231	0.0243
Invested Capital	0.0764	0.001423	8.05E-4	0.12	0.14	0.13
Operating Cash Flow Per Share	15.34	19.33	22.01	6.53	12.84	13.48
Stock Based Compensation To Revenue	0.0154	0.0163	0.0175	0.0217	0.0229	0.0241
Capex To Depreciation	(0.94)	(0.73)	(0.72)	(0.9)	(0.83)	(0.81)
Pb Ratio	1.92	1.76	1.65	1.3	1.08	2.15
Ev To Sales	4.68	6.56	7.55	4.74	3.91	4.1
Free Cash Flow Per Share	12.04	16.0	17.96	2.7	7.47	7.85
Roic	0.0288	0.0322	0.0279	0.0344	0.0289	0.0274
Net Income Per Share	58.93	128.13	142.61	(121.79)	(21.82)	(20.73)
Days Of Inventory On Hand	191.73	205.02	162.94	212.61	229.76	148.82
Payables Turnover	4.03	3.67	3.06	3.74	8.68	6.59
Research And Ddevelopement To Revenue	0.12	0.087	0.0877	0.089	0.093	0.0917
Capex To Revenue	(0.0426)	(0.0389)	(0.0413)	(0.0407)	(0.0587)	(0.0616)
Cash Per Share	37.54	33.48	29.35	60.31	55.22	57.98
Pocfratio	24.12	30.16	34.33	64.41	25.15	15.18
Interest Coverage	9.81	18.8	315.56	12.66	7.76	7.37
Capex To Operating Cash Flow	(0.22)	(0.17)	(0.18)	(0.59)	(0.42)	(0.44)
Pfcf Ratio	30.73	36.42	42.07	155.99	43.21	45.37
Days Payables Outstanding	99.36	119.38	119.28	97.49	42.04	54.57
Income Quality	0.79	0.26	0.15	(0.0536)	(0.59)	(0.56)
Roe	0.0899	0.31	0.39	(0.38)	(0.0729)	(0.0693)
Ev To Operating Cash Flow	23.63	29.04	33.63	68.34	27.83	17.4
Pe Ratio	6.28	4.55	5.3	(3.45)	(14.8)	(14.06)
Return On Tangible Assets	0.23	0.31	0.25	(0.28)	(0.0551)	(0.0524)
Ev To Free Cash Flow	30.11	35.06	41.22	165.5	47.8	50.19
Earnings Yield	0.16	0.22	0.19	(0.29)	(0.0676)	(0.0642)
Intangibles To Total Assets	0.0512	0.0379	0.0338	0.0547	0.0597	0.0567
Net Debt To E B I T D A	(0.57)	(1.13)	(0.71)	1.15	1.74	1.42
Current Ratio	2.41	3.39	2.92	5.55	5.83	6.12
Tangible Book Value Per Share	179.12	315.39	438.0	298.02	274.13	287.84
Receivables Turnover	5.89	6.07	6.9	5.67	5.33	3.78
Graham Number	505.67	978.19	1.2K	940.55	383.3	402.46
Shareholders Equity Per Share	192.84	331.9	458.15	322.82	299.26	314.22

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Rad's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.

	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

4.797

Earnings Share

(10.59)

Revenue Per Share

90.024

Quarterly Revenue Growth

(0.1)

Return On Assets

0.0169

The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Bio Historical Financial Ratios

About Bio Financial Ratios Analysis

Bio Rad Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Bio Rad fundamentals Correlations

Bio Rad Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bio Rad fundamentals Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Bio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 0.99	Pocfratio
Free Cash Flow Per Share	+ 0.98	Operating Cash Flow Per Share
Roe	+ 0.94	Net Income Per Share
Ev To Sales	+ 0.93	Book Value Per Share

Days Payables Outstanding	- 0.98	Payables Turnover
Days Of Inventory On Hand	- 0.98	Inventory Turnover
Capex To Depreciation	- 0.87	Invested Capital
Capex To Operating Cash Flow	- 0.71	Pb Ratio
Capex To Operating Cash Flow	- 0.71	Invested Capital
Capex To Operating Cash Flow	- 0.71	Ptb Ratio